Molecular analysis using SalvGlandDx improves risk of malignancy estimation and diagnosis of salivary gland cytopathology: An exploratory multicenter study
Cancer Cytopathology · 2024
DOI: 10.1002/cncy.22814 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Cancer Cytopathology, 2024. Verfasst von Sandra N Freiberger und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology and Molecular Pathology, University Hospital Zurich, Zurich, Switzerland. Hauptthemen laut MEDLINE: Salivary Gland Neoplasms. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Hoofd- en halskankerfonds Walter Vandeputte - KU Leuven, Iten-Kohaut Foundation, Kurt and Senta Herrmann Foundation.
Abstract (Originalsprache)
Background
Diagnosis of salivary gland neoplasms is challenging, especially on cytological specimens acquired by fine‐needle aspiration. The recently implemented standardized Milan system for reporting salivary gland cytopathology provides an estimated risk of malignancy (ROM); yet, for two of the categories, the diagnosis of the lesion remains unclear. However, a precise diagnosis is desirable for optimal patient management, including planning of surgery and imaging procedures.
Methods
Cytological specimens ( n = 106) were subjected to molecular analysis using the SalvGlandDx panel. The risk of malignancy was calculated for each detected alteration based on the diagnosis of the resection specimen. By taking into account the molecular alterations, their associated ROM, the clinical and cytological features, and the current literature, the Milan category was evaluated.
Results
Of n = 63 technically valid cases, 76% revealed a molecular alteration. A total of 94% of these molecularly altered cases could be assigned to a different Milan category when additionally taking molecular results into account. In only 2% of the salivary gland neoplasms of uncertain malignant potential, in which a molecular alteration was detected, the classification remained salivary gland neoplasms of uncertain malignant potential.
Conclusion
Molecular analysis of cytological specimens provides a benefit in classifying salivary gland neoplasms on fine‐needle aspiration. It can improve the ROM estimation and thus help to assign cases of formerly unknown malignant potential to clearly benign or malignant categories.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pathology and Molecular Pathology, University Hospital Zurich, Zurich, Switzerland.
- Department of Pathology, Leiden University Medical Center, Leiden, Netherlands.
- Department of Human Genetics, University Hospitals Leuven, Leuven, Belgium.
- Department of Otorhinolaryngology, Head and Neck Surgery, University Hospital Zurich, Zurich, Switzerland.
- Department of Oncology, Section Experimental Oncology, Leuven Cancer Institute, KU Leuven, Leuven, Belgium.
- Otorhinolaryngology-Head and Neck Surgery, University Hospitals Leuven, Leuven Cancer Institute, Leuven, Belgium.
ORCID-Profile: Sandra N Freiberger
Förderung
- Hoofd- en halskankerfonds Walter Vandeputte - KU Leuven
- Iten-Kohaut Foundation
- Kurt and Senta Herrmann Foundation
- Zurich Cancer League
Zitieren
APA
Freiberger, S. N., Ikenberg, K., van Egmond, D., Claerhout, S., van Wezel, T., Bempt, I. V., van Rossem, J. N., Mueller, S. A., Clement, P. M., Poorten, V. V., Cohen, D., Hauben, E., & Rupp, N. J. (2024). Molecular analysis using SalvGlandDx improves risk of malignancy estimation and diagnosis of salivary gland cytopathology: An exploratory multicenter study. Cancer Cytopathology. https://doi.org/10.1002/cncy.22814
Vancouver
Freiberger SN, Ikenberg K, van Egmond D, Claerhout S, van Wezel T, Bempt IV, et al. Molecular analysis using SalvGlandDx improves risk of malignancy estimation and diagnosis of salivary gland cytopathology: An exploratory multicenter study. Cancer Cytopathology. 2024. doi:10.1002/cncy.22814
BibTeX
@article{Freiberger2024,
author = {Freiberger, Sandra N and Ikenberg, Kristian and van Egmond, Demi and Claerhout, Sofie and van Wezel, Tom and Bempt, Isabelle Vanden and van Rossem, Jeroen N and Mueller, Simon A and Clement, Paul M and Poorten, Vincent Vander and Cohen, Danielle and Hauben, Esther and Rupp, Niels J},
title = {Molecular analysis using SalvGlandDx improves risk of malignancy estimation and diagnosis of salivary gland cytopathology: An exploratory multicenter study},
journal = {Cancer Cytopathology},
year = {2024},
doi = {10.1002/cncy.22814}
}
EUVIMED